- Previous Close
134.40 - Open
134.04 - Bid 135.50 x 200
- Ask 146.18 x 200
- Day's Range
133.81 - 137.50 - 52 Week Range
75.22 - 153.93 - Volume
488,265 - Avg. Volume
699,228 - Market Cap (intraday)
7.251B - Beta (5Y Monthly) 0.98
- PE Ratio (TTM)
92.25 - EPS (TTM)
1.47 - Earnings Date Nov 5, 2024 - Nov 11, 2024
- Forward Dividend & Yield --
- Ex-Dividend Date Nov 23, 2012
- 1y Target Est
155.00
Masimo Corporation develops, manufactures, and markets various patient monitoring technologies, and automation and connectivity solutions worldwide. The company offers masimo signal extraction technology (SET) pulse oximetry with measure-through motion and low perfusion pulse oximetry monitoring to address the primary limitations of conventional pulse oximetry; Masimo rainbow SET platform, including rainbow SET Pulse CO-Oximetry products that allows noninvasive monitoring of carboxyhemoglobin, methemoglobin, hemoglobin concentration, fractional arterial oxygen saturation, oxygen content, pleth variability index, rainbow pleth variability index, respiration rate from the pleth, and oxygen reserve index, as well as acoustic respiration monitoring, SedLine brain function monitoring, NomoLine capnography and gas monitoring, and regional oximetry. It also provides brain function and hemodynamic monitoring solutions; patient position and activity tracking, and neuromodulation technology solutions; and Masimo Hospital Automation platform, including hospital automation solutions, including Patient SafetyNet, Patient SafetyNet Surveillance, SafetyNet, Replica, Iris, MyView, UniView, Uniview: 60, Masimo Sleep, Centroid, and Bridg; and nasal high-flow ventilation, neuromodulation therapeutics, and telehealth solutions. In addition, the company provides its products through direct sales force, distributors, and original equipment manufacturers partners to hospitals, emergency medical service and home care providers, long-term care facilities, physician offices, veterinarians, and consumers; and home wellness products through e-commerce internet sites, such as masimopersonalhealth.com, amazon.com, and shopify.com. Masimo Corporation was incorporated in 1989 and is headquartered in Irvine, California.
www.masimo.comRecent News: MASI
View MorePerformance Overview: MASI
Trailing total returns as of 10/2/2024, which may include dividends or other distributions. Benchmark is
.YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: MASI
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: MASI
View MoreValuation Measures
Market Cap
7.19B
Enterprise Value
7.92B
Trailing P/E
91.46
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
3.61
Price/Book (mrq)
5.25
Enterprise Value/Revenue
3.93
Enterprise Value/EBITDA
34.93
Financial Highlights
Profitability and Income Statement
Profit Margin
3.94%
Return on Assets (ttm)
3.00%
Return on Equity (ttm)
5.93%
Revenue (ttm)
2.02B
Net Income Avi to Common (ttm)
79.4M
Diluted EPS (ttm)
1.47
Balance Sheet and Cash Flow
Total Cash (mrq)
129.6M
Total Debt/Equity (mrq)
63.08%
Levered Free Cash Flow (ttm)
120.2M
Research Analysis: MASI
View MoreCompany Insights: MASI
MASI does not have Company Insights
Research Reports: MASI
View MoreWhat does Argus have to say about MASI?
MASIMO CORP has an Investment Rating of HOLD; a target price of $121.000000; an Industry Subrating of Low; a Management Subrating of Medium; a Safety Subrating of Medium; a Financial Strength Subrating of Medium; a Growth Subrating of Medium; and a Value Subrating of Medium.
RatingPrice TargetRaising target price to $121.00
MASIMO CORP has an Investment Rating of HOLD; a target price of $121.000000; an Industry Subrating of Low; a Management Subrating of Medium; a Safety Subrating of Medium; a Financial Strength Subrating of Medium; a Growth Subrating of Medium; and a Value Subrating of Medium.
RatingPrice TargetLowering target price to $122.00
MASIMO CORP has an Investment Rating of HOLD; a target price of $122.000000; an Industry Subrating of Low; a Management Subrating of Medium; a Safety Subrating of Medium; a Financial Strength Subrating of Low; a Growth Subrating of Medium; and a Value Subrating of Medium.
RatingPrice TargetLowering target price to $128.00
MASIMO CORP has an Investment Rating of HOLD; a target price of $128.000000; an Industry Subrating of Low; a Management Subrating of Medium; a Safety Subrating of Medium; a Financial Strength Subrating of Low; a Growth Subrating of Medium; and a Value Subrating of Medium.
RatingPrice Target